This medicine has been identified as being suitable for inclusion on the Amber List of specialist medicines.
The Regional Group on Specialist Medicines have determined that a regional shared care guideline is not required for this medicine.
In the absence of a regional shared care guideline, consultants should ensure that GPs are provided with sufficient information to enable them to safely prescribe these medicines for each individual patient.